Case ReportInternational Journal of Basic & Clinical Pharmacology
Publication: Imiquimod triggering varicella zoster reactivation in an immunocompetent patient
Int J Basic Clin Pharmacol. 2017;6(4):990-992.DOI10.18203/2319-2003.ijbcp20171117
Abstract
Imiquimod is widely used for the treatment of superficial basal cell carcinoma as well as several other dermatologic conditions. While its local immunostimulatory action is well proven, its potential for systemic immunomodulation has been less well described. We report the first case (to our knowledge) of varicella zoster reactivation caused by Imiquimod in an immunocompetent patient.
Keywords
Affiliations
- Department of Dermatology, Research fellow, Southern Suburbs Dermatology, Sydney, Australia
- Department of Dermatology, Southern Suburbs Dermatology, Sydney, Australia
- Department of Dermatology, Dermatologic surgeon and Managing Director, Southern Suburbs Dermatology Conjoint senior lecturer, University of New South Wales, Australia